References
- Phillips I, King A, Shannon K. In vitro properties of the quinolones. The quinolones, V T Andriole. Academic Press, London 1988; 83–117
- Wolfson J S, Hooper D C, Swartz M N. Mechanisms of action and of resistance to quinolone antimicrobial agents. Quinolone antimicrobial agents, J S Wolfson, D C Cooper. American Society for Microbiology, Washington, DC 1989; 5–34
- Wolfson J S, Hooper D C. Introduction. Quinolone antimicrobial agents, J S Wolfson, D C Cooper. American Society for Microbiology, Washington, DC 1989; 1–4
- Ericsson H M, Sherris J C. Antibiotic sensitivity testing. Report of an International Collaborative Study. Acta Pathol Microbiol Scand 1971, Suppl 217
- Pocock S J. Clinical trials, a practical approach. John Wiley & Sons, New York 1983; 123–125
- Dobson A D. An introduction to statistical modeling. Chapman and Hall, London 1983, Chap. 8
- Fass R J, Plouffe J F, Russell J A. Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections. Am J Med 1989; 87(Suppl 5A)165S–168S
- Forsgren A. Overview of Scandinavian in vitro studies with ciprofloxacin. Scand J Infect Dis, Suppl 1989; 60: 16–22
- Kahn F A, Basir R. Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory infections. Chest 1989; 96: 528–537
- Haddow A, Greene S, Heinz G, Wantuck D. Ciprofloxacin (intravenous/oral) versus ceftazidime in lower respiratory tract infections. Am J Med 1989; 87(Suppl 5A)113S–115S
- Basran G S, Joseph J, Abbas A MA, Hughes C, Tillotson G S. Treatment of acute exacerbations of chronic obstructive airways disease - a comparison of amoxycillin and ciprofloxacin. J Antimicrob Chemother 1990; 26(Suppl F)19–24
- Modai J. The French Multicenter Study Group. Treatment of serious infections with intravenous ciprofloxacin. Am J Med 1989; 87(Suppl 5A)243S–247S
- Eliopoulos G M, Eliopoulos C T. Quinolone antibacterial agents: activity in vitro. Quinolone antimicrobial agents, J S Wolfson, D C Cooper. American Society for Microbiology, Washington, DC 1989; 35–70
- Limson B M. Use of quinolones in typhoid fever. Quinolones Bull 1989; 5: 17–18
- Barry A L, Jones R N. In vitro activity of ciprofloxacin against Gram-positive cocci. Am J Med 1987; 82(Suppl 4A)27–32
- Daly J S, Worthington M G, Razvi S A, Robillard R. Brief report. Intravenous and sequential intravenous and oral ciprofloxacin in the treatment of severe infections. Am J Med 1989; 87(Suppl 5A)232S–234S
- Kresken M, Wiedemann B. Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin. Antimicrob Agents Chemother 1988; 32: 1285–1288
- Oppenheim B A, Hartley J W, Lee W, Burnie J P. Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit. BMJ 1989; 299: 294–297